The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL)
暂无分享,去创建一个
Li Yan | Lars Kjeldsen | Marsha A. Moses | L. Kjeldsen | M. Moses | Li Yan | N. Borregaard | Niels Borregaard
[1] M. Mizumoto,et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. , 1998, Cancer letters.
[2] Donald E. Ingber,et al. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. , 2000, Journal of cell science.
[3] H. Sengeløv,et al. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. , 1994, Blood.
[4] W. Stetler-Stevenson,et al. Matrix metalloproteinases and metastasis , 1999, Cancer Chemotherapy and Pharmacology.
[5] M. Lindstrom,et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.
[6] D. Isenberg,et al. Serum metalloproteinases and their inhibitors: markers for malignant potential. , 1994, British Journal of Cancer.
[7] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[8] L. Liotta,et al. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. , 1992, Cancer research.
[9] J. Cowland,et al. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.
[10] M. Kress,et al. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. , 1989, Oncogene.
[11] H. Sengeløv,et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.
[12] K. Ohlsson,et al. Studies of the release and turnover of a human neutrophil lipocalin. , 1995, Scandinavian journal of clinical and laboratory investigation.
[13] M A Moses,et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. , 1998, Cancer research.
[14] E. Howard,et al. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.
[15] L. Liotta,et al. Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] B. Nielsen,et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.
[17] M A Moses,et al. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.
[18] S. Maśliński,et al. Activation of the latent human neutrophil gelatinase by urea. , 1991, Acta biochimica Polonica.
[19] M. Farquhar,et al. THE PERMEABILITY OF GLOMERULAR CAPILLARIES TO GRADED DEXTRANS , 1974, The Journal of cell biology.
[20] Z. Werb,et al. The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progression a , 1998, Annals of the New York Academy of Sciences.
[21] W. Stetler-Stevenson,et al. Plasma Assay of Matrix Metalloproteinases (MMPs) and MMP‐Inhibitor Complexes in Cancer , 1994, Annals of the New York Academy of Sciences.
[22] Gould Mn,et al. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. , 1995 .
[23] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.